ERVK-21 Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP22081c
Background:
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.
Other Names:
Endogenous retrovirus group K member 21 Env polyprotein, EnvK1 protein, Envelope polyprotein, HERV-K_12q14.1 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERVK-21
Target/Specificity:
The synthetic peptide sequence is selected from aa 291-302 of HUMAN ERVK-21
Gene Name: ERVK-21
Primary Accession: P61565
Other Accession: Q902F9;O42043;O71037;P61566;P61570;Q9HDB8;Q69384;P61567;Q902F8;Q9UKH3;P63135
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.
Other Names:
Endogenous retrovirus group K member 21 Env polyprotein, EnvK1 protein, Envelope polyprotein, HERV-K_12q14.1 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERVK-21
Target/Specificity:
The synthetic peptide sequence is selected from aa 291-302 of HUMAN ERVK-21
Gene Name: ERVK-21
Primary Accession: P61565
Other Accession: Q902F9;O42043;O71037;P61566;P61570;Q9HDB8;Q69384;P61567;Q902F8;Q9UKH3;P63135
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review